Protara Therapeutics, Inc. (TARA) Capital expenditures 2016–2025
Protara Therapeutics, Inc. (TARA) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$94,000FY2025 · since FY2016: $271,000 → $94,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $94,000 | +49.2% |
| FY2024 | $63,000 | +40.0% |
| FY2023 | $45,000 | -62.5% |
| FY2022 | $120,000 | -79.9% |
| FY2021 | $596,000 | -32.6% |
| FY2020 | $884,000 | +86.1% |
| FY2019 | $475,000 | +299.2% |
| FY2018 | $119,000 | +240.0% |
| FY2017 | $35,000 | -87.1% |
| FY2016 | $271,000 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice